Overexpression of pulmonary IL-13 in transgenic mice led to development of features typical of asthma, such as eosinophilic airway inflammation, increased mucus production, sub-epithelial fibrosis and airway hyper-responsiveness [2]. Here, IL13 is linked to asthma.